IRADIMED CORP Form 8-K Summary
Business Context and Reporting Period
IRADIMED CORPORATION (NASDAQ: IRMD) filed a Current Report on Form 8-K on February 13, 2025. The filing announces the financial results for the quarter ended December 31, 2024, via a press release furnished as Exhibit 99.1.
Key Financial Metrics
The provided filing text serves as a cover document and does not contain specific numerical data. Consequently, values for revenue, profit, cash flow, margins, debt, and liquidity are not present in this text. Investors must refer to the attached press release (Exhibit 99.1) for these figures.
Material Changes
The filing text does not disclose specific material changes or comparative performance metrics versus the prior period. Such details are contained within the referenced press release.
Guidance, Outlook, and Risks
This 8-K filing does not include management commentary, forward-looking guidance, risk factors, or contingencies. The document explicitly states that the information in Item 2.02 and Exhibit 99.1 is not deemed "filed" for purposes of Section 18 of the Exchange Act and is not incorporated by reference except as expressly set forth.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release dated February 13, 2025) for actual Q4 2024 financial results.
- Verify specific revenue, net income, and cash flow figures in the press release as they are absent from the 8-K text.
- Check for any updated guidance or outlook provided in the press release.
- Confirm the filing status of the press release information, noting it is furnished but not "filed" under Section 18.